Eli Lilly to transfer rights of two diabetes products to Cip

NEW DELHI, Oct 4: Drug firm Eli Lilly and Company (India) on Monday said it has inked a pact with Cipla to enhance the reach of its two diabetes products

Related Keywords

Gurgaon , Haryana , India , Vikas Gupta , Luca Visini , Eli Lilly , Cipla , Company India On , Lilly Diabetes , Cipla Head , India Prescription Business , Lilly India ,